Vir Biotechnology, Inc. VIR Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s operating cash flow?
- Vir Biotechnology, Inc. (VIR) reported operating cash flow of -$132.39M in Q1 2026.
- How has Vir Biotechnology, Inc.'s operating cash flow changed year-over-year?
- Vir Biotechnology, Inc.'s operating cash flow decreased by 69.5% year-over-year, from -$78.12M to -$132.39M.
- What is the long-term trend for Vir Biotechnology, Inc.'s operating cash flow?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s operating cash flow has grown at a -38.2% compound annual growth rate (CAGR), from $1.66B to -$391.78M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.